The Protective Effects of Carvacrol Against Doxorubicin-Induced Cardiotoxicity In Vitro and In Vivo
Rini Retnosari,Muhamad Adib Abdul Ghani,Munirah Majed Alkharji,Wan Nur Izzah Shazana Wan Nawi,Ahmad Syafi Ahmad Rushdan,Mohd Kaisan Mahadi,Azizah Ugusman,Natsuhisa Oka,Satirah Zainalabidin,Jalifah Latip
DOI: https://doi.org/10.1007/s12012-024-09940-8
2024-11-28
Cardiovascular Toxicology
Abstract:Doxorubicin (DOX) is a remarkable chemotherapeutic agent, however, its adverse effect on DOX-induced cardiotoxicity (DIC) is a rising concern. Recent research has identified carvacrol (CAR), an antioxidant and anti-inflammatory agent, as a promising natural compound for protecting against DIC. This study aims to investigate the potential cardioprotective effects properties of CAR in vitro and in vivo. The cardioprotective effect of CAR was assessed by pretreating H9c2 cells with non-toxic CAR for 24 h, followed by co-treatment with DOX (10 μM) for an additional 24 h. The cell viability was determined using an MTT assay. For the in vivo study, male Sprague–Dawley rats (200–250 g) were randomly divided into three groups: control, cardiotoxicity (DOX), and treatment (CAR + DOX) groups. CAR (50 mg/kg, BW) was administered orally to the CAR + DOX groups for 14 days. Then, a single dose of DOX (15 mg/kg/i.p, BW) was administered on day 15 for DOX and CAR + DOX groups. The rats were allowed to recover for 3 days before being sacrificed. Our results demonstrated that DOX (10 μM) significantly reduced H9c2 cell viability by 50% ( p < 0.0001), and CAR (0.067 μM) protected H9c2 cells from DIC ( p = 0.0045). In the rat model, CAR pretreatment effectively mitigated DOX-induced reductions in systolic pressure ( p = 0.0007), pulse pressure ( p = 0.0213), hypertrophy ( p = 0.0049), and cardiac fibrosis ( p = 0.0006). However, the pretreatment did not alter the heart function, oxidative stress, and antioxidant enzymes. In conclusion, our results indicate that CAR could potentially serve as an adjuvant to reduce cardiotoxicity by ameliorating myocardial fibrosis and hypertrophy.
cardiac & cardiovascular systems,toxicology